Genetically engineered cellular nanoparticles loaded with curcuminoids for cancer immunotherapy
Theranostics · 2024 · 14 (16) · 6409-6425
DOI: 10.7150/thno.99033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2024. Verfasst von Yifang Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Programmed Cell Death 1 Receptor, Curcumin. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- School of Medicine, South China University of Technology, Guangzhou 510006, China.
- Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China.
- Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Zitieren
APA
Liao, Y., Zhao, C., Pan, Y., Guo, Y., Liu, L., Wu, J., Zhang, Y., Rao, L., & Li, Q. (2024). Genetically engineered cellular nanoparticles loaded with curcuminoids for cancer immunotherapy. Theranostics, 14(16), 6409-6425. https://doi.org/10.7150/thno.99033
Vancouver
Liao Y, Zhao C, Pan Y, Guo Y, Liu L, Wu J, et al. Genetically engineered cellular nanoparticles loaded with curcuminoids for cancer immunotherapy. Theranostics. 2024;14(16):6409-6425. doi:10.7150/thno.99033
BibTeX
@article{Liao2024,
author = {Liao, Yifang and Zhao, Chenchen and Pan, Yuanwei and Guo, Yiming and Liu, Lujie and Wu, Jicheng and Zhang, Yunjiao and Rao, Lang and Li, Qi},
title = {Genetically engineered cellular nanoparticles loaded with curcuminoids for cancer immunotherapy},
journal = {Theranostics},
year = {2024},
volume = {14},
number = {16},
pages = {6409--6425},
doi = {10.7150/thno.99033}
}
EUVIMED